Literature DB >> 21385079

Marked increase in CYP24A1 gene expression in human papillary thyroid cancer.

Bernadett Balla, János P Kósa, Bálint Tobiás, Csaba Halászlaki, István Takács, Henrik Horváth, Gábor Speer, Zsolt Nagy, János Horányi, Balázs Járay, Eszter Székely, Péter Lakatos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21385079     DOI： 10.1089/thy.2010.0420

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  11 in total

1.  Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.

Authors:  M P Yavropoulou; G Panagiotou; K Topouridou; G Karayannopoulou; T Koletsa; T Zarampoukas; A Goropoulos; E Chatzaki; J G Yovos; K Pazaitou-Panayiotou
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

2.  Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma.

Authors:  Marissa Penna-Martinez; Elizabeth Ramos-Lopez; Julienne Stern; Heinrich Kahles; Nora Hinsch; Martin-Leo Hansmann; Ivan Selkinski; Frank Grünwald; Christian Vorländer; Wolf O Bechstein; Stefan Zeuzem; Katharina Holzer; Klaus Badenhoop
Journal:  Thyroid       Date:  2012-06-12       Impact factor: 6.568

3.  Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer.

Authors:  B Balla; B Tobiás; J P Kósa; J Podani; P Horváth; Z Nagy; J Horányi; B Járay; E Székely; L Krenács; K Árvai; M Dank; Z Putz; B Szabó; B Szili; Z Valkusz; B Vasas; G Győri; P Lakatos; I Takács
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

4.  Cyp24a1 Attenuation Limits Progression of BrafV600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720.

Authors:  Minjing Zou; Essa Y Baitei; Huda A BinEssa; Futwan A Al-Mohanna; Ranjit S Parhar; René St-Arnaud; Shioko Kimura; Catrin Pritchard; Ali S Alzahrani; Abdullah M Assiri; Brian F Meyer; Yufei Shi
Journal:  Cancer Res       Date:  2017-02-27       Impact factor: 12.701

5.  Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter.

Authors:  Lihong Zhang; Jing Shi; Li Xu; Bingyin Shi; Peng Hou; Meiju Ji
Journal:  Thyroid Res       Date:  2011-10-12

6.  Inflammatory conditions induce IRES-dependent translation of cyp24a1.

Authors:  Daniela Rübsamen; Michael M Kunze; Victoria Buderus; Thilo F Brauß; Magdalena M Bajer; Bernhard Brüne; Tobias Schmid
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

Review 7.  Insights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer.

Authors:  Grégoire B Morand; Sabrina Daniela da Silva; Michael P Hier; Moulay A Alaoui-Jamali
Journal:  Front Oncol       Date:  2014-11-04       Impact factor: 6.244

Review 8.  Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis.

Authors:  Julia Höbaus; Ursula Thiem; Doris M Hummel; Enikö Kallay
Journal:  Anticancer Agents Med Chem       Date:  2013-01       Impact factor: 2.505

9.  Cell-type specific features of circular RNA expression.

Authors:  Julia Salzman; Raymond E Chen; Mari N Olsen; Peter L Wang; Patrick O Brown
Journal:  PLoS Genet       Date:  2013-09-05       Impact factor: 5.917

10.  Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy.

Authors:  Julia Höbaus; Samawansha Tennakoon; Petra Heffeter; Charlotte Groeschel; Abhishek Aggarwal; Doris M Hummel; Ursula Thiem; Rodrig Marculescu; Walter Berger; Enikö Kállay
Journal:  Int J Cancer       Date:  2015-08-17       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.